Florfenicol-resistant Brevundimonas sanguinis sp. nov., a novel bacterium isolated from patient blood in South Korea
Antonie van Leeuwenhoek · 2025
DOI: 10.1007/s10482-024-02020-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antonie van Leeuwenhoek, 2025. Verfasst von Ji Hee Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathogen Resource Management, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Preventi…. Hauptthemen laut MEDLINE: Phylogeny, RNA, Ribosomal, 16S, Caulobacteraceae, DNA, Bacterial. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea National Institute of Health.
Abstract (Originalsprache)
An aerobic, Gram-stain-negative, non-motile, non-spore-forming, short rod-shaped bacterial strain, designated NCCP 15609 T, was isolated from the blood sample of a patient in the Republic of Korea. The strain was identified as Brevundimonas diminuta using MALDI-TOF. A phylogenetic tree constructed using 16S rRNA gene sequences revealed that the isolate was of the genus Brevundimonas with 99.8% similarity to B. naejangsanensis. The strain NCCP 15609T genome consisted of one contig with 3,063,090 bp, and had a G+C content of 67.4%. The genome contained 2,949 protein-coding sequences, 52 tRNAs, and 6 rRNAs. The DNA-DNA hybridisation between NCCP 15609T and B. naejangsanensis yielded 92.5% and 49.5% ± 2.6%, respectively, using the average nucleotide identity (ANI) and digital DNA-DNA hybridisation (dDDH). The predominant fatty acids of strain NCCP 15609T were summed feature 8 (C18:1 ω7c/C18:1 ω6c) and C16:0. The isolate contained polar lipids and quinone, corresponding to phosphatidylglycerol, 1,2-di-O-acyl-3-O-[D-glycopyranosyl (1 → 4)-α-D-glucopyranuronosyl] glycerol, and ubiquinone-10, respectively. Based on its phylogenetic, physiological, and chemotaxonomic characteristics, we suggest that NCCP 15609T represents a novel pathogen resource of the genus Brevundimonas and propose to name it Brevundimonas sanguinis sp. nov. The type strain is NCCP 15609T (= DSM 116005T).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pathogen Resource Management, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency (KDCA), Cheongju, 28160, Republic of Korea.
- Division of Pathogen Resource Management, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency (KDCA), Cheongju, 28160, Republic of Korea. tenksy@korea.kr.
Förderung
- Korea National Institute of Health
Zitieren
APA
Lee, J. H., An, Y., & Kim, S. Y. (2025). Florfenicol-resistant Brevundimonas sanguinis sp. nov., a novel bacterium isolated from patient blood in South Korea. Antonie van Leeuwenhoek. https://doi.org/10.1007/s10482-024-02020-5
Vancouver
Lee JH, An Y, Kim SY. Florfenicol-resistant Brevundimonas sanguinis sp. nov., a novel bacterium isolated from patient blood in South Korea. Antonie van Leeuwenhoek. 2025. doi:10.1007/s10482-024-02020-5
BibTeX
@article{Lee2025,
author = {Lee, Ji Hee and An, Yewon and Kim, Su Yeon},
title = {Florfenicol-resistant Brevundimonas sanguinis sp. nov., a novel bacterium isolated from patient blood in South Korea},
journal = {Antonie van Leeuwenhoek},
year = {2025},
doi = {10.1007/s10482-024-02020-5}
}
EUVIMED